SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-047360
Filing Date
2023-09-11
Accepted
2023-09-11 08:04:08
Documents
12
Period of Report
2023-09-10
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K life-20230910.htm   iXBRL 8-K 58554
  Complete submission text file 0000950170-23-047360.txt   177153

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT life-20230910_pre.xml EX-101.PRE 10992
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT life-20230910_lab.xml EX-101.LAB 13360
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT life-20230910.xsd EX-101.SCH 2470
6 EXTRACTED XBRL INSTANCE DOCUMENT life-20230910_htm.xml XML 4710
Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

IRS No.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37378 | Film No.: 231246729
SIC: 2836 Biological Products, (No Diagnostic Substances)